Early CRP kinetics predict long-term treatment success and favorable outcomes of anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinoma

Kluemper N, Sikic D, Saal J, Buettner T, Jarczyk J, Zeuschner P, Weinke M, Kalogirou C, Breyer J, Burger M, Nuhn P, Tully K, Roghmann F, Bolenz C, Zengerling F, Wirtz R, Muders M, Kristiansen G, Ellinger J, Wullich B, Holzel M, Hartmann A, Erben P, Ritter M, Eckstein M (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Oncology Research and Treatment Karger Publishers

Publisher: KARGER

City/Town: BASEL

Pages Range: 12-12

Conference Proceedings Title: ONCOLOGY RESEARCH AND TREATMENT

Authors with CRIS profile

Bernd Wullich Lehrstuhl für Urologie Arndt Hartmann Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie Markus Eckstein Institute of Pathology

Involved external institutions

Universitätsklinikum Bonn DE Germany (DE) Universitätsklinikum Mannheim DE Germany (DE) Universitätsklinikum des Saarlandes (UKS) DE Germany (DE) Universitätsklinikum Würzburg DE Germany (DE) Universität Regensburg DE Germany (DE) Ruhr-Universität Bochum (RUB) DE Germany (DE) Universitätsklinikum Ulm DE Germany (DE) STRATIFYER Molecular Pathology GmbH DE Germany (DE)

How to cite

APA:

Kluemper, N., Sikic, D., Saal, J., Buettner, T., Jarczyk, J., Zeuschner, P.,... Eckstein, M. (2022). Early CRP kinetics predict long-term treatment success and favorable outcomes of anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinoma. In ONCOLOGY RESEARCH AND TREATMENT (pp. 12-12). BASEL: KARGER.

MLA:

Kluemper, Niklas, et al. "Early CRP kinetics predict long-term treatment success and favorable outcomes of anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinoma." Proceedings of the ONCOLOGY RESEARCH AND TREATMENT BASEL: KARGER, 2022. 12-12.

BibTeX: Download